Financial Performance - The company's operating revenue for Q3 2025 reached ¥120,365,001.32, representing an increase of 11.63% compared to the same period last year[5]. - Net profit attributable to shareholders was ¥30,041,068.73, up 24.63% year-on-year, while the net profit after deducting non-recurring gains and losses was ¥29,275,379.60, an increase of 22.69%[5]. - Total operating revenue for the current period reached ¥361,855,940.26, an increase of 12.3% compared to ¥322,154,559.44 in the previous period[22]. - Net profit for the current period was ¥77,979,748.99, representing a growth of 19.6% from ¥65,198,956.27 in the previous period[23]. - The company reported a basic and diluted earnings per share of ¥1.3240, down from ¥1.4760 in the previous period, a decrease of 10.3%[24]. Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥1,989,519,183.31, reflecting an 8.38% increase from the end of the previous year[5]. - Total assets increased from 1,835,668,196.00 CNY to 1,989,519,183.31 CNY, reflecting a growth of about 8.4%[20]. - The total liabilities increased to ¥1,043,386,216.94 from ¥851,992,581.16, marking a rise of 22.5%[21]. - The company’s total liabilities decreased by 50.63% in other current liabilities, amounting to ¥9,852,633.42, due to a reduction in advance receipts[10]. Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥139,118,481.73, showing a significant increase of 32.52%[13]. - The net cash flow from operating activities increased to ¥139,118,481.73, compared to ¥104,981,315.74 in the last period, reflecting a rise of 32.4%[24]. - Cash inflows from operating activities totaled ¥580,923,551.19, compared to ¥430,969,821.51 in the previous period, an increase of 34.7%[24]. - The net cash flow from financing activities was negative at -¥131,683,894.49, a significant decrease of 3993.50% due to dividends and issuance costs[14]. - The net cash flow from financing activities was -131,683,894.49, indicating a significant outflow compared to the previous period's -3,216,901.06[25]. - The net increase in cash and cash equivalents for the period was -253,900,529.61, indicating a decrease in liquidity[25]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 8,670[15]. - The largest shareholder, Tong Lei, holds 17.27% of shares, totaling 10,169,000 shares[15]. - The number of shares held by the top ten shareholders accounts for a significant portion of the total shares, indicating concentrated ownership[15]. - The company has no preferred shareholders as of the reporting period[16]. Other Financial Metrics - The company experienced a 34.08% increase in inventory, amounting to ¥609,248,371.74, due to an increase in project execution[10]. - Research and development expenses were ¥30,934,764.30, up 10.9% from ¥27,896,139.79 in the previous period, indicating continued investment in innovation[23]. - The company recorded a net cash outflow from investing activities of ¥259,344,289.64, compared to an outflow of ¥1,304,412.45 in the previous period, indicating increased investment activity[24]. - The impact of exchange rate changes on cash and cash equivalents was -1,990,827.21, reflecting a negative effect on liquidity[25]. - The company distributed dividends and interest payments totaling 115,160,336.76 during the period[25]. Audit Status - The third quarter financial report was not audited, which may affect the reliability of the reported figures[26].

Group 1 - The core point of the article is that 博科测试 (Boke Testing) has stated on its investor interaction platform that the company currently has no chip testing cases [1] Group 2 - The company is involved in the testing industry but is not currently engaged in chip testing [1] - The announcement may indicate a focus on other testing areas or a lack of demand for chip testing services at this time [1] - This information could be relevant for investors assessing the company's market position and future opportunities [1]

Core Viewpoint - 博科测试 is a supplier that provides intelligent testing comprehensive solutions through modern testing and experimental technologies, focusing on servo hydraulic testing equipment and automotive testing equipment [1] Company Overview - 博科测试 specializes in the research, design, manufacturing, sales, and system integration of servo hydraulic testing equipment and automotive testing experimental equipment [1]

Group 1 - The company, Boke Testing, reported that as of October 20, 2025, the total number of shareholders (including both ordinary accounts and margin trading accounts) is 9,040 [2]

Core Viewpoint - The company, Boke Testing (301598), has developed advanced seismic simulation testing systems for various nuclear power users, which will also be applied in controlled nuclear fusion power plants [1] Group 1 - The company provides world-class seismic simulation testing systems for nuclear power facilities [1] - These systems support users in the research, design, and construction of various nuclear facilities [1] - The company is committed to monitoring the development and application of cutting-edge technologies in the nuclear field [1]

Core Viewpoint - The company has developed advanced seismic simulation testing systems for various nuclear power users, which will support the research, design, and construction of nuclear facilities, including controlled nuclear fusion power plants [1] Group 1 - The company has provided seismic simulation testing systems that meet world-class standards [1] - These systems are utilized for research, design, and construction of various nuclear facilities [1] - The company will continue to focus on the development and application of cutting-edge technologies in the nuclear field [1]

Core Insights - On October 15, 2023, Boke Testing's stock increased by 0.29% with a trading volume of 84.69 million yuan [1] - The company reported a net financing outflow of 1.37 million yuan on the same day, with a total financing balance of 85.49 million yuan, accounting for 8.51% of its market capitalization [1][2] - Boke Testing's main business revenue composition includes 78.59% from automotive testing solutions and 20.71% from servo hydraulic testing solutions [1] Financial Performance - For the first half of 2025, Boke Testing achieved a revenue of 241 million yuan, representing a year-on-year growth of 12.67% [2] - The net profit attributable to the parent company for the same period was 47.94 million yuan, reflecting a year-on-year increase of 16.65% [2] - Cumulative cash dividends since the company's A-share listing amount to 118 million yuan [2] Shareholder Information - As of October 10, 2023, the number of shareholders for Boke Testing was 8,485, a decrease of 2.13% from the previous period [2] - The average number of circulating shares per shareholder increased by 2.18% to 1,735 shares [2] - As of June 30, 2025, a significant shareholder, Chunhou Xinrui A, exited the top ten circulating shareholders list [2]

北京博科测试系统股份有限公司 董事会薪酬与考核委员会关于 2025 年限制性股票激励计划 授予激励对象名单的核查意见（截至授予日） （5）法律法规规定不得参与上市公司股权激励的； （6）中国证监会认定的其他情形。 3、本次激励计划授予激励对象均为在本公司（含子公司，下同）任职的高 级管理人员、核心技术（业务）骨干人员。所有激励对象均与公司具有劳动或聘 用关系。激励对象中无独立董事，无单独或合计持有公司 5%以上股份的股东或 实际控制人及其配偶、父母、子女。 4、本激励计划授予的激励对象均具备《公司法》《证券法》等法律法规和 规范性文件以及《公司章程》规定的任职资格，符合《管理办法》《上市规则》 北京博科测试系统股份有限公司（以下简称"公司"）董事会薪酬与考核委 员会根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民 共和国证券法》（以下简称"《证券法》"）、《上市公司股权激励管理办法》 （以下简称"《管理办法》"）、《深圳证券交易所创业板股票上市规则》（以 下简称"《上市规则》"）、《深圳证券交易所创业板上市公司自律监管指南第 1 号——业务办理》（以下简称"《自律监管指南第 1 号》"）及《 ...

北京博科测试系统股份有限公司 2025 年限制性股票激励计划激励对象名单 （截至授予日） 2025 年限制性股票激励计划（以下简称"激励计划"）授予的限制性股票 在各激励对象间的分配情况如下表所示： 董事会 | 序号 | 姓名 | 职务 | 本次获授的限 制性股票数量 | 占授予第二 类限制性股 | 占本激励计划 草案公告日公 | | --- | --- | --- | --- | --- | --- | | | | | | 票总数的比 | 司股本总额的 | | | | | （万股） | 例 | 比例 | | 1 | 段鲁男 | 董事、总经理 | 15.00 | 13.95% | 0.25% | | 2 | 田金 | 董事、副总经理 | 7.00 | 6.51% | 0.12% | | 3 | 王永浩 | 董事 | 7.00 | 6.51% | 0.12% | | 4 | 张慧燕 | 财务负责人、董 事会秘书 | 6.00 | 5.58% | 0.10% | | | 核心技术（业务）骨干人员（21 | | 52.50 | 48.84% | 0.89% | | | 人） 合计 | | 87.50 | 81.40 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 北京博科测试系统股份有限公司（以下简称"公司"）于 2025 年 10 月 15 日召开第四届董事会第六次会议，审议通过了《关于调整公司 2025 年限制性股 票激励计划授予价格的议案》。根据《北京博科测试系统股份有限公司 2025 年 限制性股票激励计划（草案）》（以下简称"《激励计划（草案）》"）的规定 及公司 2025 年第四次临时股东会的授权，董事会同意将授予价格由 33.20 元/股 调整为 32.50 元/股。现将有关事项说明如下： 证券代码：301598 证券简称：博科测试 公告编号：2025-054 北京博科测试系统股份有限公司 关于调整公司 2025 年限制性股票激励计划授予价格的公告 一、本次激励计划已履行的决策程序和信息披露情况 （一）2025 年 9 月 19 日，公司召开的第四届董事会第五次会议审议通过了 《关于<2025 年限制性股票激励计划（草案）>及其摘要的议案》《关于<2025 年限制性股票激励计划实施考核管理办法>的议案》《关于提请股东会授权董事 会办理 2025 年限制性股票 ...